Argentina Proving Popular with CROs

A report by GBI Research has highlighted Argentina's increasing popularity as a cost-effective yet high-quality place to conduct clinical trials.

Contract research organisations (CROs) are increasingly viewing Argentina as a suitable place for investment, new research has found.

Healthcare expert GBI Research has published a new report on the pharmaceutical and biotechnology industry in Argentina, which benefits from a good clinical infrastructure, cost compliance and favourable regulatory environment, as well as a large population.

According to the report, these factors are helping to make Argentina an attractive option for CROs, which can often make significant financial savings by outsourcing clinical trials to the country without lowering their quality standards.

This is because its clinical research regulations are aligned with inte